Sorry, you need to enable JavaScript to visit this website.

Don't accept
second best.

See why Dexcom is the
#1 preferred CGM among
Canadian Endocrinologists

 

Image
Don't accept second best  - - en

Complete this form to order a sample of Dexcom G7 today. 

 

Request a Dexcom G7 sample

It's easy to introduce your diabetes patients to the power of Dexcom rtCGM with a FREE 10-day sample. Patients must have a compatible smart device (sold separately): dexcom.com/compatibility.
 
Fields marked with an * are required. You may choose to provide the optional information to help us assign the appropriate representative to assist you with your inquiry.
 
 

A response will not be provided for inquiries from outside of Canada.

Please see dexcom.com for information on our consumer products.
*Stay up-to-date with Dexcom
Would you like to stay up-to-date with Dexcom products, educational events and news via email?
By choosing to opt-in, you are granting DexCom, Inc. and Dexcom Canada, Co. (together "Dexcom")permission to process the personal data you have provided so that we may send you additional information and communications by email related to Dexcom products from time-to-time. You may opt-out of these solicitations at any time by selecting the unsubscribe link at the bottom of any email or by contacting us by email at [email protected] or by mail at the address listed in Contact Us, and you may opt-in again through one of those contacts. Dexcom respects the privacy and confidentiality of your personal information. We will not share your personal information with any third-parties, except as otherwise noted in our Privacy Policy.
LBL-1004197 Rev001

CGM = continuous glucose monitoring.
* Based on a survey of Canadian endocrinologists (n=41). 
† Based on commercially available CGM systems as of May 1, 2025. 
‡ Audible and visual notification of predictive alert at 3.1 mmol/L within 20 minutes.  

1 dQ&A, Dexcom Canadian Endos Report Wave 1 2024. 
2 Dexcom, Data on file, 2025. 
3 Beck RW, et al. JAMA. 2017;317(4):371-378. 
4 Beck RW, et al. Ann Intern Med. 2017;167(6) 365-374. 
5 Martens T, et al. JAMA. 2021;325(22):2262-2272. 
6 Leffel LM, et al. JAMA. 2020;323(23):2388-2396. 
7 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147. 
8 Dexcom G7 User Guide. 

Dexcom and Dexcom G7 are registered trademarks of Dexcom, Inc. in the U.S. and may be registered in other countries.© 2025 Dexcom Canada, Co. All rights reserved. MAT-8255 Vl.0